🇺🇸 FDA
Patent

US 10500246

Compositions for delivery to and treatment of atherosclerotic plaques

granted A61KA61K31/195A61K38/08

Quick answer

US patent 10500246 (Compositions for delivery to and treatment of atherosclerotic plaques) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/195, A61K38/08, A61K45/06, A61K47/543